Business Insights
The Pharmaceutical Outsourcing Series from Business Insights provides a unique insight into the key issues surrounding contract research and contract manufacturing.
HOME | ABOUT THE SERIES | CONTRACT RESEARCH | CONTRACT MANUFACTURING | THE REPORTS | CONTACT US  
 
Contract Research


Contract Research Outsourcing publications.

Optimizing Partnerships with Contract Organizations: Effective management, key issues and the development of virtual pharmacos
Click here for further information on this report

OUT NOW!
Key Trends in Offshoring Pharmaceutical R&D
Click here for further information on this report


For a Full list of new and upcoming Pharmaceutical Outsourcing titles, consult the report section of the site

Business Insights' Healthcare Portfolio
To find out about our other Healthcare titles please follow the link: Business Insights Healthcare.

CONTRACT RESEARCH

The future of outsourcing

Contract research organizations

Contract research organisations (CROs) are experiencing high growth, now employing more than 100,000 workers and accounting for $14bn in R&D spending by pharma and biotech companies - approximately 20% of the overall pharma and biotech R&D budget. Revenues are forecast to continue increasing at an annual rate of 14 – 16% through 2010 and will amount to $23bn by 2010.

"Outsourcing of R&D presents the opportunity to reduce bottlenecks in the R&D process, cut R&D costs, improve trial design and gain access to new patient groups. In particular, companies are increasingly looking to China and India to outsource their R&D, where outsourcing clinical trials has the advantage of reaching a larger/denser population and 'treatment naive' patients. In India, for example, there are good hospital and clinical facilities, a large population base and the data processing infrastructure for bioformatics. However, the growth of CRO activity is constrained by important regulatory issues both in the developing world and countries from where R&D is outsourced."

See diagram below for details of where our new reports can help your strategic planning

Diagram: Establishing and maintaining partnerships with contract organisations.

Patient recruitment and retention strategies.

Our new outsourcing portfolio of reports is designed to help decision makers:

  • Plan resources and budgets effectively
  • Understand the future role of CROs in improving pharma productivity
  • Optimizing performance of outsourced companies as part of the R&D process

 

 
Business Insights